HSD17B8
(3R)-3-hydroxyacyl-CoA dehydrogenase
Also known as: D6S2245E, DHB8_HUMAN, FABGL, H2-KE6, HKE6, KE6, RING2, SDR30C1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q92506
- Gene
- HSD17B8
- Ensembl
- ENSG00000204228
- Chromosome
- 6
- Canonical length
- 261 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins
OverviewNCBI Gene
In mice, the Ke6 protein is a 17-beta-hydroxysteroid dehydrogenase that can regulate the concentration of biologically active estrogens and androgens. It is preferentially an oxidative enzyme and inactivates estradiol, testosterone, and dihydrotestosterone. However, the enzyme has some reductive activity and can synthesize estradiol from estrone. The protein encoded by this gene is similar to Ke6 and is a member of the short-chain dehydrogenase superfamily. An alternatively spliced transcript of this gene has been detected, but the full-length nature of this variant has not been determined. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
261 residues, UniProt reviewed canonical sequence.
>Q92506|HSD17B8
1 MASQLQNRLR SALALVTGAG SGIGRAVSVR LAGEGATVAA CDLDRAAAQE TVRLLGGPGS
61 KEGPPRGNHA AFQADVSEAR AARCLLEQVQ ACFSRPPSVV VSCAGITQDE FLLHMSEDDW
121 DKVIAVNLKG TFLVTQAAAQ ALVSNGCRGS IINISSIVGK VGNVGQTNYA ASKAGVIGLT
181 QTAARELGRH GIRCNSVLPG FIATPMTQKV PQKVVDKITE MIPMGHLGDP EDVADVVAFL
241 ASEDSGYITG TSVEVTGGLF MLocalizationUniProt · AlphaFold · HPA
Whether an antibody against HSD17B8 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.26
- Highest tissue expression
- 63 nTPM
Expression across tissuesHPA
Tissue
- liver: 63 nTPM
- pancreas: 54 nTPM
- parathyroid gland: 40 nTPM
- kidney: 34 nTPM
- thyroid gland: 31 nTPM
- epididymis: 28 nTPM
Single-cell type
- hepatocytes: 78 nCPM
- esophageal suprabasal cells: 62 nCPM
- epididymal efferent duct absorptive cells: 60 nCPM
- plasma cells: 59 nCPM
- enterocytes: 56 nCPM
- epididymal efferent duct ciliated cells: 54 nCPM
Immune cell
- MAIT T-cell: 30 nTPM
- memory CD8 T-cell: 29 nTPM
- naive CD8 T-cell: 29 nTPM
- total PBMC: 27 nTPM
- naive CD4 T-cell: 27 nTPM
- memory CD4 T-cell: 24 nTPM
Brain region
- medulla oblongata: 11 nTPM
- midbrain: 9.6 nTPM
- spinal cord: 8.3 nTPM
- white matter: 7.9 nTPM
- thalamus: 7.6 nTPM
- choroid plexus: 7.5 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.09
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.43
- DepMap mean gene effect
- 0.08
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- androgen metabolic process
- estrogen biosynthetic process
- fatty acid biosynthetic process
- protein heterotetramerization
Molecular functions
- (3R)-3-hydroxyacyl-CoA dehydrogenase (NAD+) activity
- estradiol 17-beta-dehydrogenase [NAD(P)+] activity
- NADH binding
- quinone binding
- testosterone dehydrogenase (NAD+) activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads HSD17B8 as an antibody target. Whether an autoantibody or antibody against HSD17B8 could matter depends on whether native HSD17B8 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
HSD17B8 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label HSD17B8 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...